English
contrastBtngrayscaleBtn oku-icon

|

plusBtn crossBtn minusBtn

|

This site
is mobile
responsive

sticky-logo

Novartis Malaysia Opens the Doors Of Its New Hybrid Office As Part Of Footprint Expansion In Malaysia

Novartis Malaysia Opens the Doors Of Its New Hybrid Office As Part Of Footprint Expansion In Malaysia

• Re-imagined office re-designs work experiences and future ways of working suited to today’s post Covid-19 world.
• Award winning intuitive office that adapts to differing work modes, moods and needs of associate.
• Hosted special showcase for key stakeholders in government and business associations.

Petaling Jaya, June 14, 2022 – Novartis Malaysia, a leading medicines company continues to solidify it’s presence in market with the reveal of a new state-of-the-art office in Plaza Imazium, Damansara Uptown. More than just a change of address, the new office is part of the company’s strategic growth plan and commitment to future-proofing its business to better serve customers.

Spread over two floors, the office completely redesigns today’s work experience for its associates by placing flexibility at the core and prioritizing human connections and collaborations.

Established in 1972, Novartis Malaysia has evolved tremendously from a small office to a leading player in the healthcare industry hosting three key divisions comprising Innovative Medicines (Pharma and Oncology), Sandoz (Biosimiliars) and the Novartis Global Service Centre Kuala Lumpur (NGSC KL) – one of only five global shared centres in the world. NGSC KL which launched in 2016 has grown in a short span of six yeas from servicing five countries to 25 markets, including Novartis’s own headquarters in Basel, Switzerland with high end, data and digital enabled working solutions.

Mr. Patrik Grande, Country President Novartis Malaysia said:

“For Novartis to achieve its goal and its vision of reimagining medicine, it is critical for future-forward work environments to go hand-in-hand with equally agile business environments. Malaysia’s conducive and adaptive business-friendly support and infrastructure have a key component to our current footprint that has expanded to more than 800 associates in Malaysia, serving 32 million customers across the country.”

“Over the five decades that Novartis has been in Malaysia, Kuala Lumpur’s attractiveness as a regional and global hub has continued to improve, with attractive government incentives, a strong pipeline of key talents, robust infrastructure and ever expanding healthcare market.”

In 2021, Novartis Malaysia contributed over RM1billion to Malaysia’s gross domestic product (GDP), with nearly a quarter coming from its business activities; employed over 80% of Malaysians in high-value jobs; invested over RM4 million in research and development, including 38 clinical trials and real-world evidence generation programmes for several key therapeutic areas; supported local businesses as well as contributed over RM3 million to help protect frontliners and high-risk communities against Covid-19.

According to Grande, Novartis Malaysia intends to continuously grow its engagement with the government and support in strengthening the healthcare system in Malaysia through the smart use of digital and technological innovations that applies Real World Evidence (RWE) in order to guide solutions that can improve patient journeys.

“As part of delivering on our vision and mission, we aim, to be a healthcare partner of choice for our customers. A key priority for Novartis Malaysia continues to be our focus on exploring further Public Private Partnerships (PPPs) in the realm of clinical trials and healthcare system strengthening,” he added.

In support of its expansion plan, YB Dato’ Sri Mustapa Bin Mohamed, Minister in the Prime Minister’s Department (Economy), and Her Excellency Ambassador Andrea Reichlin, Ambassador of Switzerland to Malaysia, graced the showcase of Novartis Malaysia’s new office.

In his keynote address at the showcase, Mustapa said, “ The growth trajectory of Novartis’ footprint in Malaysia is really a feat worth emulating. From hosting a small office in the country 50 years ago to currently being one of the biggest investors in the Malaysian pharmaceutical market. In these trying times, it is indeed heartening to see leading pharmaceutical companies like Novartis’ continuous commitment in Malaysia.”

“With the opening of Novartis Malaysia’s new office that centres on data and digital while envisioning a future working model taking into consideration their staff’s diverse needs, Novartis is leading the way in showing other Multi National Company’s and investors the direction of holistic growth and innovation that Malaysia as a country wants to emulate,” Mustapa added.

Datuk Arham Abdul Rahman, Chief Executive Officer of the Malaysian Investment Development Authority (MIDA) congratulated Novartis Malaysia on their new space, saying “Over 50 years ago, Novartis stepped foot in Malaysia. Today, the Novartis Global Services Center Kuala Lumpur is home to its Operational Headquarters, serving the entire Asia Pacific Region. This evolution speaks volumes of the company’s confidence in Malaysia, as well as our country’s ability in rising to meet the expectations of leading life sciences companies to not only be future ready but to lead in today’s increasingly hybrid world. MIDA wishes Novartis Malaysia all the best ahead and look forward to the company further leveraging Malaysia’s business ecosystem to grow and serve its customers in the region and beyond for the years to come.”

Chief Executive Officer of InvestKL, Muhammad Azmi Zulkifli said “Novartis Malaysia’s new office reflects great confidence and reinforces Greater Kuala Lumpur as a location of choice for leading global companies. This office not only spearheads the transformation of work but also marks a significant milestone of growth supported by Kuala Lumpur’s diverse talent, strategic location, IR4.0 driven economy and solid infrastructure. We look forward to facilitating more innovative and high-tech investments into Malaysia and to continuously support Novartis’s growth in the region.”

An office for the truly Inspired, Curious & Unbossed

Novartis Malaysia’s new office encapsulates the new Ways of Working (WoW) – Team-aligned, Associate-Led, and Manager-Enabled. Therefore, having an office that places flexibility at the core but prioritizes human connections and collaboration for associates to deliver purposeful and high impact will unleash the power of the over 800 talents who work here.

Additionally, the office has been thoughtfully curated with key enablers and elements in place. It incorporates an Activity-Based Workplace concept which allows associates to leverage the different sections and corners that best cater to their meeting, collaboration or wellbeing needs. The company is also big on driving the adoption of data and digital for associates to embrace digital technologies and data science to work in new ways and create better patient outcomes.

The office is also sustainability-driven with the use of environmental-friendly and recycled materials for its furniture and computer monitors. Thanks to these efforts, the office has been recognized as one of 20 LEED-Gold certified offices and the first WELL-Silver certified (office) in the country.

Earlier this year, Novartis Malaysia addded another feather to its cap by winning Top Employer 2022, having also won for consecutive years of 2021 and 2020. Novartis Malaysia also hosts one of 5 Novartis Global Service Centres worldwide, which have all been certified as Top Employer 3 years in a row. The award recognizes excellence in working environment and further underscores its Inspired, Curious and Unbossed culture.

As a leading medicines company powered by advanced therapy platforms and data science, Novartis Malaysia proved its capability by winning the Medical Technology – Pharmaceuticals award for its predictive tool AXON at the Malaysia Technology Excellence Awards 2022 recently.

*****

About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library
For questions about the site or required registration, please contact [email protected]

About Novartis Malaysia
Novartis Malaysia has been present in Malaysia since 1971. Following the merger of Sandoz and Ciba-Geigy, Novartis was formed in 1996. In 2015, Kuala Lumpur was chosen as one of the five Novartis Global Service Centres, which offers IT, HR Services, FRA Operations, Product Lifecycle Services, and Procurement Services to the Novartis group of companies worldwide. In 2021, Novartis was ranked the top contributor by the Clinical Research Malaysia in sponsored research with 16 research projects, leading the market of other healthcare players in this sponsored research space.

TwitterLinkedInFacebookWhatsApp
wpChatIcon
X